JCI - Citations to Genetics of kidney failure and the evolving story of APOL1

Citations to this article

Genetics of kidney failure and the evolving story of APOL1

David J. Friedman, Martin R. Pollak

David J. Friedman, Martin R. Pollak

Published September 1, 2011
Citation Information: J Clin Invest. 2011;121(9):3367-3374. https://doi.org/10.1172/JCI46263.

View: Text | PDF

Science in Medicine

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	Total
Citations:	4	4	7	2	1	3	11	9	6	6	8	5	4	1	71

Citation information

Citations to this article (71)

Title and authors	Publication	Year
Development of a culturally targeted chatbot to inform living kidney donor candidates of African ancestry about APOL1 genetic testing: a mixed methods study. Gordon EJ, Gacki-Smith J, Gooden MJ, Waite P, Yacat R, Abubakari ZR, Duquette D, Agrawal A, Friedewald J, Savage SK, Cooper M, Gilbert A, Muhammad LN, Wicklund C	Journal of Community Genetics	2024
Unveiling APOL1 haplotypes in a predominantly African-American cohort of kidney transplant patients: a novel classification using probe-independent quantitative real-time PCR Dogan M, Watkins C, Ingram H, Moore N, Rucker GM, Gower EG, Eason JD, Bhalla A, Talwar M, Nezakatgoo N, Eymard C, Helmick R, Vanatta J, Bajwa A, Kuscu C, Kuscu C	Frontiers in Medicine	2024
Advancements in Research on Genetic Kidney Diseases Using Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids. Na DH, Cui S, Fang X, Lee H, Eum SH, Shin YJ, Lim SW, Yang CW, Chung BH	Cells	2024
Mechanistic insights into redox damage of the podocyte in hypertension Ilatovskaya DV, Behr A, Staruschenko A, Hall G, Palygin O	Hypertension (Dallas, Tex. : 1979)	2024
APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene − Proceedings of the Henry Shavelle Professorship Pollak MR, Friedman DJ		2023
Genetics of Chronic Kidney Disease in Low-Resource Settings. Ilori T, Watanabe A, Ng KH, Solarin A, Sinha A, Gbadegesin R	Seminars in Nephrology	2023
Management of traditional risk factors for the development and progression of chronic kidney disease Lo R, Narasaki Y, Lei S, Rhee CM	Clinical Kidney Journal	2023
Hidden genetics behind glomerular scars: an opportunity to understand the heterogeneity of focal segmental glomerulosclerosis? Mitrotti A, Giliberti M, Di Leo V, di Bari I, Pontrelli P, Gesualdo L, Mitrotti A, Giliberti M, Di Leo V, di Bari I, Pontrelli P, Gesualdo L	Pediatric nephrology (Berlin, Germany)	2023
How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside Piras D, Lepori N, Cabiddu G, Pani A	Journal of Personalized Medicine	2022
Comparative Analysis of the APOL1 Variants in the Genetic Landscape of Renal Carcinoma Cells Tzukerman M, Shamai Y, Abramovich I, Gottlieb E, Selig S, Skorecki K	Cancers	2022
APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program Hung AM, Shah SC, Bick AG, Yu Z, Chen HC, Hunt CM, Wendt F, Wilson O, Greevy RA, Chung CP, Suzuki A, Ho YL, Akwo E, Polimanti R, Zhou J, Reaven P, Tsao PS, Gaziano JM, Huffman JE, Joseph J, Luoh SW, Iyengar S, Chang KM, Casas JP, Matheny ME, O\u2019Donnell CJ, Cho K, Tao R, Susztak K, Robinson-Cohen C, Tuteja S, Siew ED	JAMA internal medicine	2022
Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice Yang YW, Poudel B, Frederick J, Dhillon P, Shrestha R, Ma Z, Wu J, Okamoto K, Kopp JB, Booten SL, Gattis D, Watt AT, Palmer M, Aghajan M, Susztak K	Molecular Therapy	2022
Ion channels and channelopathies in glomeruli Staruschenko A, Ma R, Palygin O, Dryer SE	Physiological reviews	2022
Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations Giudicelli GC, De Souza CM, Veronese FV, Pereira LV, Hünemeier T, Vianna FS	Frontiers in Genetics	2022
Genetics in Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference	Kidney International	2022
Nutrition Intervention for Reduction of Cardiovascular Risk in African Americans Using the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines KA Williams, I Fughhi, S Fugar, M Mazur, S Gates, S Sawyer, H Patel, D Chambers, R McDaniel, JR Reiser, T Mason	Nutrients	2021
Evolution of Renal-Disease Factor APOL1 Results in Cis and Trans Orientations at the Endoplasmic Reticulum That Both Show Cytotoxic Effects D Müller, J Schmitz, K Fischer, D Granado, AC Groh, V Krausel, SM Lüttgenau, TM Amelung, H Pavenstädt, T Weide, H Malik	Molecular Biology and Evolution	2021
APOL1 Nephropathy: From Genetics to Clinical Applications DJ Friedman, MR Pollak	Clinical journal of the American Society of Nephrology : CJASN	2020
Association of APOL1 renal disease risk alleles with Trypanosoma brucei rhodesiense infection outcomes in the northern part of Malawi K Kamoto, H Noyes, P Nambala, E Senga, J Musaya, B Kumwenda, B Bucheton, A Macleod, A Cooper, C Clucas, C Herz-Fowler, E Matove, AM Chiwaya, JE Chisi, A Benkahla	PLoS neglected tropical diseases	2019
APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore SS Shah, H Lannon, L Dias, JY Zhang, SL Alper, MR Pollak, DJ Friedman	Journal of the American Society of Nephrology : JASN	2019
Apolipoprotein L1, cardiovascular disease and hypertension: More questions than answers Patel N, Nadkarni GN	Cardiology Clinics	2019
Genes and environment in chronic kidney disease hotspots: DJ Friedman	Current Opinion in Nephrology and Hypertension	2018
APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease P Beckerman, K Susztak	Trends in Molecular Medicine	2018
APOL1 risk variants and kidney disease: what we know so far TA Siemens, MC Riella, TP de Moraes, CV Riella		2018
Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors: JE Locke, D Sawinski, RD Reed, B Shelton, PA MacLennan, V Kumar, S Mehta, RB Mannon, R Gaston, BA Julian, JJ Carr, JG Terry, M Kilgore, AB Massie, DL Segev, CE Lewis	Annals of Surgery	2018
Ethnicity matching and outcomes after kidney transplantation in the United Kingdom B Pisavadia, A Arshad, I Chappelow, P Nightingale, B Anderson, J Nath, A Sharif, K Eller	PloS one	2018
An Exome-wide Association Study for Type 2 Diabetes–Attributed End-Stage Kidney Disease in African Americans M Guan, JM Keaton, L Dimitrov, PJ Hicks, J Xu, ND Palmer, JG Wilson, BI Freedman, DW Bowden, MC Ng	Kidney International Reports	2018
Directed differentiation of human induced pluripotent stem cells into mature kidney podocytes and establishment of a Glomerulus Chip S Musah, N Dimitrakakis, DM Camacho, GM Church, DE Ingber	Nature Protocols	2018
How Omics Data Can Be Used in Nephrology EP Rhee	American journal of kidney diseases : the official journal of the National Kidney Foundation	2018
APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults OM Gutiérrez, MR Irvin, NS Chaudhary, M Cushman, NA Zakai, VA David, S Limou, N Pamir, AP Reiner, RP Naik, MM Sale, MM Safford, HI Hyacinth, SE Judd, JB Kopp, CA Winkler	Circulation. Genomic and precision medicine	2018
Racial Disparities in Nephrology Consultation and Disease Progression among Veterans with CKD: An Observational Cohort Study J Suarez, JB Cohen, V Potluri, W Yang, DE Kaplan, M Serper, SP Shah, PP Reese	Journal of the American Society of Nephrology : JASN	2018
A National Survey of Transplant Surgeons and Nephrologists on Implementing Apolipoprotein L1 ( APOL1) Genetic Testing Into Clinical Practice Gordon EJ, Wicklund C, Lee J, Sharp RR, Friedewald J		2018
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice P Beckerman, J Bi-Karchin, AS Park, C Qiu, PD Dummer, I Soomro, CM Boustany-Kari, SS Pullen, JH Miner, CA Hu, T Rohacs, K Inoue, S Ishibe, MA Saleem, MB Palmer, AM Cuervo, JB Kopp, K Susztak	Nature Medicine	2017
Prospects for Precision Medicine in Glomerulonephritis Treatment YC Liu, J Chun	Canadian Journal of Kidney Health and Disease	2017
Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip S Musah, A Mammoto, TC Ferrante, SS Jeanty, M Hirano-Kobayashi, T Mammoto, K Roberts, S Chung, R Novak, M Ingram, T Fatanat-Didar, S Koshy, JC Weaver, GM Church, DE Ingber	Nature Biomedical Engineering	2017
Diversity and inclusion in genomic research: why the uneven progress? AR Bentley, S Callier, CN Rotimi	Journal of Community Genetics	2017
Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease K Harding, TB Mersha, FA Webb, JA Vassalotti, SB Nicholas	American Journal of Nephrology	2017
Genome-wide association studies of albuminuria: towards genetic stratification in diabetes? C Pattaro	Journal of Nephrology	2017
Race, Genomics and Chronic Disease: What Patients with African Ancestry Have to Say CR Horowitz, K Ferryman, R Negron, T Sabin, M Rodriguez, RF Zinberg, E Böttinger, M Robinson	Journal of health care for the poor and underserved	2017
The functionality of African-specific variants in the TGFB1 regulatory region and their potential role in HIVAN M Nel, JM Buys, FC Botha, N Wearne, S Prince, JM Heckmann	Clinical and Experimental Nephrology	2017
Donor and Recipient Ethnicity Impacts Renal Graft Adverse Outcomes JM Kwan, Z Hajjiri, YF Chen, A Metwally, DL Perkins, PW Finn	Journal of Racial and Ethnic Health Disparities	2017
Apolipoprotein L1 and Kidney Disease in African Americans DJ Friedman, MR Pollak	Trends in Endocrinology & Metabolism	2016
Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans J Ma, M Guan, DW Bowden, MC Ng, PJ Hicks, JP Lea, L Ma, C Gao, ND Palmer, BI Freedman	Clinical journal of the American Society of Nephrology : CJASN	2016
APOL1 Risk Alleles Are Associated With More Severe Arteriosclerosis in Renal Resistance Vessels With Aging and Hypertension MD Hughson, WE Hoy, SA Mott, VG Puelles, JF Bertram, CA Winkler, JB Kopp	Kidney International Reports	2016
Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial G Bodonyi-Kovacs, JZ Ma, J Chang, MS Lipkowitz, JB Kopp, CA Winkler, TH Le	Journal of the American Society of Nephrology : JASN	2016
APOL1-G1 in Nephrocytes Induces Hypertrophy and Accelerates Cell Death Y Fu, J Zhu, A Richman, Y Zhang, X Xie, JR Das, J Li, PE Ray, Z Han	Journal of the American Society of Nephrology : JASN	2016
Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac Catheterization H Wang, PH Pun, L Kwee, D Craig, C Haynes, M Chryst-Ladd, LP Svetkey, UD Patel, ER Hauser, MR Pollak, WE Kraus, SH Shah	Cardiorenal Medicine	2016
APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases OA Olabisi, JY Zhang, L VerPlank, N Zahler, S DiBartolo, JF Heneghan, JS Schlöndorff, JH Suh, P Yan, SL Alper, DJ Friedman, MR Pollak	Proceedings of the National Academy of Sciences	2015
Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy SL Saraf, X Zhang, B Shah, T Kanias, KP Gudehithlu, R Kittles, RF Machado, JA Arruda, MT Gladwin, AK Singh, VR Gordeuk	Haematologica	2015
Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study Y Yamada, K Matsui, I Takeuchi, T Fujimaki	International journal of molecular medicine	2015
Socioeconomic Disparities in Chronic Kidney Disease SB Nicholas, K Kalantar-Zadeh, KC Norris	Advances in Chronic Kidney Disease	2015
APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study WE Hoy, MD Hughson, JB Kopp, SA Mott, JF Bertram, CA Winkler	Journal of the American Society of Nephrology : JASN	2015
Actualizing the Benefits of Genomic Discovery in Pediatric Nephrology M Sampson	Journal of pediatric genetics	2015
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1 B Nichols, P Jog, JH Lee, D Blackler, M Wilmot, V D'Agati, G Markowitz, JB Kopp, SL Alper, MR Pollak, DJ Friedman	Kidney International	2014
Gene-Gene and Gene-Environment Interactions in Apolipoprotein L1 Gene-Associated Nephropathy BI Freedman, K Skorecki	Clinical journal of the American Society of Nephrology : CJASN	2014
Kidney Transplant Access in the Southeast: View From the Bottom: View From the Bottom RE Patzer, SO Pastan	American Journal of Transplantation	2014
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial CD Langefeld, J Divers, NM Pajewski, AT Hawfield, DM Reboussin, DE Bild, GA Kaysen, PL Kimmel, DS Raj, AC Ricardo, JT Wright, JR Sedor, MV Rocco, BI Freedman	Kidney International	2014
Histopathologic findings associated with APOL1 risk variants in chronic kidney disease CP Larsen, ML Beggs, M Saeed, JM Ambruzs, LN Cossey, NC Messias, PD Walker, BI Freedman	Modern Pathology	2014
Genetic Variants and Risk of Chronic Kidney Disease O Devuyst	Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis	2014
Explaining the Racial Difference in AKI Incidence ME Grams, K Matsushita, Y Sang, MM Estrella, MC Foster, A Tin, WH Kao, J Coresh	Journal of the American Society of Nephrology : JASN	2014
Genetic Variation and Adaptation in Africa: Implications for Human Evolution and Disease F Gomez, J Hirbo, SA Tishkoff	Cold Spring Harbor perspectives in biology	2014
A Consideration of Genetic Mechanisms Behind the Development of Hypertension in Blacks W Tu, JH Pratt	Current Hypertension Reports	2013
Population Ancestry and Genetic Risk for Diabetes and Kidney, Cardiovascular, and Bone Disease: Modifiable Environmental Factors May Produce the Cures BI Freedman, J Divers, ND Palmer	American Journal of Kidney Diseases	2013
Lifetime incidence of CKD stages 3-5 in the United States ME Grams, EK Chow, DL Segev, J Coresh	American journal of kidney diseases : the official journal of the National Kidney Foundation	2013
Increased Burden of Cardiovascular Disease in Carriers of APOL1 Genetic Variants K Ito, AG Bick, J Flannick, DJ Friedman, G Genovese, MG Parfenov, SR DePalma, N Gupta, SB Gabriel, HA Taylor, ER Fox, C Newton-Cheh, S Kathiresan, JN Hirschhorn, DM Altshuler, MR Pollak, JG Wilson, JG Seidman, C Seidman	Circulation research	2013
Is it variants in the apolipoprotein l1 gene, or blood pressure control, that predicts progression of nondiabetic hypertensive nephropathy in African Americans? Cohen DL, Townsend RR	Journal of clinical hypertension (Greenwich, Conn.)	2013
Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians BO Tayo, H Kramer, BL Salako, O Gottesman, CA McKenzie, A Ogunniyi, EP Bottinger, RS Cooper	International Urology and Nephrology	2012
APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis DB Johnstone, V Shegokar, D Nihalani, YS Rathore, L Mallik, Ashish, V Zare, HO Ikizler, R Powar, LB Holzman	PloS one	2012
Influence of race, ethnicity and socioeconomic status on kidney disease RE Patzer, WM McClellan	Nature reviews. Nephrology	2012
Genetic Variants in Arhgef11 Are Associated With Kidney Injury in the Dahl Salt-Sensitive Rat JM Williams, AC Johnson, C Stelloh, AW Dreisbach, N Franceschini, KR Regner, RR Townsend, RJ Roman, MR Garrett	Hypertension	2012
Race, renal disease and albuminuria BI Freedman, DW Bowden	Nature reviews. Nephrology	2011

Advertisement